Table 2 Clinical background of patients with terminal heart failure.
Patient | Sex | Age | Cause of heart failure | NYHA | Assist | Other diseases | Tissue used for |
|---|---|---|---|---|---|---|---|
1 | M | 65 | Ischemic dilated cardiomyopathy | IIIA | No | ASD, atrial fibrillation and asthma | Proteomics IHC PCR |
2 | F | 60 | Restrictive cardiomyopathy, due to amyloidosis | IIIA | No | PAH, asthma, amyloidosis and myeloma | Proteomics IHC PCR |
3 | F | 64 | Idiopathic dilated cardiomyopathy | IIIB | No | PAH, valvular disease, atrial fibrillation, diabetes type II, hypertension, renal insufficiency, hypothyreosis and previous ovarian cancer | Proteomics IHC PCR |
4 | M | 27 | Idiopathic dilated cardiomyopathy | III | Yes | PAH, atrial fibrillation | Proteomics PCR |
5 | M | 66 | Idiopathic dilated cardiomyopathy | IIIA | Yes | PAH, previous stroke and diabetes type II | IHC PCR |
6 | M | 67 | Ischemic cardiomyopathy | IIIA | Yes | PAH, previous AMI, atrial fibrillation and renal insufficiency | IHC PCR |
7 | M | 45 | Hypertrophic cardiomyopathy | IIIB | No | PAH | IHC PCR |
8 | M | 39 | Ischemic cardiomyopathy | III | No | PAH, previous AMI, valvular disease, diabetes type I, mild retinopathy and nephropathy | PCR |
9 | M | 66 | Dilated cardiomyopathy due to amyloidosis | IIIB | No | Diabetes type II and PAH | PCR |
10 | M | 50 | Ischemic dilated cardiomyopathy | IIIA | No | Diabetes type II, hypertension, and previous stroke | PCR |
11 | M | 61 | Hypertrophic cardiomyopathy | III | No | Previous stroke, previous atrial fibrillation, previous Maze surgery, renal insufficiency, COPD | PCR |
